PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsNIFTY non-invasive prenatal test scrutinised over links to Chinese military

BioNews

NIFTY non-invasive prenatal test scrutinised over links to Chinese military

Published 10 September 2021 posted in News and appears in BioNews 1112

Author

Christina Burke

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family (from Greek and Roman mythology) entwined in coils of DNA.
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family entwined in coils of DNA (based on the figure of Laocoön from Greek and Roman mythology).

Health regulators in five countries are investigating non-invasive prenatal test NIFTY, over data protection concerns....

Health regulators in five countries are investigating non-invasive prenatal test NIFTY, over data protection concerns.

Concerns were raised when Reuters claimed in July that NIFTY, marketed by Chinese company BGI Group, was developed in conjunction with the military (see BioNews 1103). Although Reuters found no evidence of data protection breaches by BGI Group, regulators are calling for greater transparency over their research purposes.

Regulators in Germany, Slovenia, Estonia, Canada, and Australia are examining the test, citing that local vendors are responsible for data protection even if samples are sent abroad.

'Genetic information is not only valuable to marketers and data brokers, but also to foreign states and cybercriminals as well,' the Office of the Information and Privacy Commission of Ontario told Reuters.

The Ontario regulator has since advised women to seek prenatal tests from Canadian providers, to ensure 'comparable' data security. Elsewhere, in Germany regulators have suspended transfer of patient data to BGI Group from Eluthia GmBH, a laboratory that sells NIFTY.

The NIFTY test, currently marketed in at least 52 countries, detects genetic abnormalities in fetuses by examining fetal DNA in the mother's blood. Patients are asked for consent for their data to be used for unspecified research purposes, such as in Hong Kong where data may be stored for five years. The consent form also specifies that data may be shared with Chinese authorities in matters of national security, though BGI Group claims it has never been asked to do so.

In its report published in July, Reuters asserted that NIFTY data were used for research such as preventing altitude sickness in Chinese soldiers, and a mass pathogen testing programme. Although BGI Group has stressed that its research only uses anonymised data, regulators are concerned that the nature of the research is not transparent.

'It is vital that the patient is provided with clear information,' said Dr Beverley Rowbotham, chair of Australia's National Pathology Accreditation Advisory Council.

BGI Group maintains that although it collaborates with military hospitals, the NIFTY test was not developed with the Chinese military. BGI Group has confirmed to Reuters that it is providing information to regulatory authorities to demonstrate its compliance with data protection laws.

Sources and References

  • 07/09/2021
    Guardian
    Prenatal gene test Nifty under international scrutiny amid links to Chinese military
  • 07/09/2021
    Reuters
    BGI prenatal gene test under scrutiny for Chinese military links

Related Articles

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1997. Depicts the gyri of the Thinker's brain as a maze of choices in biomedical ethics (based on Auguste Rodin's 'The Thinker').
CC BY 4.0
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1997. Depicts the gyri of the Thinker's brain as a maze of choices in biomedical ethics (based on the sculpture 'The Thinker' by Auguste Rodin).
News
1 October 2021 • 2 minutes read

Disparities in prenatal screening uptake revealed

by Tsvetana Stoilova

Non-invasive prenatal testing uptake in socioeconomically disadvantaged neighbourhoods of the Netherlands is significantly lower than in other parts of the country...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
9 July 2021 • 2 minutes read

China's BGI Group is using its prenatal test to harvest gene data, claims report

by Christina Burke

Genetic data from millions of prenatal blood samples are being used for population research by China, claims Reuters...

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family (from Greek and Roman mythology) entwined in coils of DNA.
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family entwined in coils of DNA (based on the figure of Laocoön from Greek and Roman mythology).
News
28 May 2021 • 2 minutes read

Illumina and Roche settle and dismiss patent lawsuits over 'Harmony' tests

A long-running court case over non-invasive prenatal testing patents has been settled...

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family (from Greek and Roman mythology) entwined in coils of DNA.
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family entwined in coils of DNA (based on the figure of Laocoön from Greek and Roman mythology).
News
5 December 2017 • 2 minutes read

Illumina wins NIPT patent case in UK High Court

by Dr Rachel Montgomery

The UK Patents Court has ruled that two separate non-invasive prenatal tests infringe patents licensed by the US firm Illumina...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
13 November 2017 • 2 minutes read

Down's syndrome blood test more accurate than existing screening

by Kirsty Oswald

Research shows that a new prenatal blood test for Down's syndrome outperforms current methods of screening...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Mini CRISPR-associated protein developed by bioengineers

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

6 July 2022 • 1 minute read

Frozen embryo transfers linked to high blood pressure in pregnancy

5 July 2022 • 1 minute read

Anorexia in pregnancy linked to increased risk of complications

5 July 2022 • 2 minutes read

Pregnancy after breast cancer treatment does not increase risk of recurrence

5 July 2022 • 1 minute read

No difference between fresh and frozen sperm for IUI

4 July 2022 • 2 minutes read

Shorter IVF protocol reduces risk of OHSS

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856